Cronos Group Inc(CRON) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 7:17 PM ET (Korea 10/28 08:17)
Full metrics table
| Index | - | P/E | 18.35 | EPS (ttm) | 0.18 | Insider Own | 50.51% | Shs Outstand | 370.7M | Perf Week | 3.05% |
| Market Cap | 1.25B | Forward P/E | 18.57 | EPS next Y | 8.33% | Insider Trans | - | Shs Float | 182.3M | Perf Month | -0.88% |
| Enterprise Value | 0.50B | PEG | - | EPS next Q | 0.03 | Inst Own | 14.37% | Short Float | 2.17% | Perf Quarter | 18.18% |
| Income | 0.07B | P/S | 6.95 | EPS this Y | 940% | Inst Trans | -0.51% | Short Ratio | 3.48 | Perf Half Y | 27.55% |
| Sales | 0.18B | P/B | 1.17 | EPS next 5Y | - | ROA | 5.94% | Short Interest | 3.96M | Perf YTD | 28.52% |
| Book/sh | 2.88 | P/C | 1.56 | EPS past 3/5Y | 61.97% 34.75% | ROE | 6.51% | 52W High | -6.31% ($3.61) | Perf Year | 36.84% |
| Cash/sh | 2.16 | P/FCF | 24.91 | Sales past 3/5Y | 19.11% 25.7% | ROIC | 6.54% | 52W Low | 48.25% ($2.28) | Perf 3Y | 96.51% |
| Dividend Est. | - | EV/EBITDA | 48.1 | EPS Y/Y TTM | 276.99% | Gross Margin | 44.99% | Volatility(W/M) | 3.71% 2.71% | Perf 5Y | -36.11% |
| Dividend TTM | - | EV/Sales | 2.78 | Sales Y/Y TTM | 37.46% | Oper. Margin | -2.19% | ATR (14) | 0.1 | Perf 10Y | 265.84% |
| Dividend Ex-Date | - | Quick Ratio | 15.25 | EPS Q/Q | 182.93% | Profit Margin | 39.08% | RSI (14) | 57.45 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 16.18 | Sales Q/Q | 58.44% | SMA20 | 3.45% ($3.27) | Beta | 0.97 | Target Price | $4.21 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/11/5 | SMA50 | 2.54% ($3.3) | Rel Volume | 0.66 | Prev Close | $3.31 |
| Employees | 610 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 800% 19.93% | SMA200 | 18.86% ($2.84) | Avg Volume(3M) | 1.14M | Price | $3.38 |
| IPO | 2016/7/12 | Option/Short | Yes/Yes | Trades | 2440 | Volume | 751,472 | Change | 2.11% |
🌿 Cronos Group (CRON) is a Canada-based company that cultivates, manufactures, and sells cannabis and cannabis-derived products. It focuses on two major markets: the Israeli medical market and the Canadian adult-use (recreational) market, operating a diversified product portfolio that includes dried flower, extracts, and edible products. The company has established a strong presence through its Peace Naturals brand in the Israeli medical cannabis market and its Spinach brand in the Canadian edible products market.
Over the past 1 year, on the higher side
6% below its 1-year high.
Traded less than usual. That is 66% of its average volume.
Next earnings report: November 5
8 days to go.
CRON has a sound balance sheet but weak earning power
Of every $100 in sales, $2.19 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +940.0% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,857. Peers typically go for $1,485. Compared with its own 2-year average, it is 18% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -36.1%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 14.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #32 of 83 in the industry
Based on market cap of $1B.
FAQ
What kind of company is CRON?
CRON belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of CRON?
The market cap of CRON is approximately $1.2B, ranking 2,422 within its sector.
What is the P/E ratio of CRON?
CRON has a P/E ratio of approximately 18.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CRON?
CRON has recorded a 52-week high of $3.61 and a low of $2.28.
